What is Tejnaksh Healthcare Ltd (539428) share price return in the past 10 years?

Tejnaksh Healthcare Ltd share price has appreciated 13.5% annually (CAGR) over the past ten years.

What is the share price of Tejnaksh Healthcare Ltd (539428)?

Company share prices are keep on changing according to the market conditions. The current trading price of Tejnaksh Healthcare Ltd (539428) on 17-Apr-2026 16:59:59 at 16:59 is 15.06.

What is the P/E ratio of Tejnaksh Healthcare?

The latest standalone P/E ratio of Tejnaksh Healthcare as of 17-Apr-2026 is 18.77.

What is the P/B ratio of Tejnaksh Healthcare Ltd (539428)?

The latest standalone P/B ratio of Tejnaksh Healthcare Ltd (539428) as of 17-Apr-2026 is 1.16.

What is the 52-week high and low of Tejnaksh Healthcare Ltd (539428)?

The 52-week high of Tejnaksh Healthcare Ltd (539428) is Rs. 24.29 and the 52-week low is Rs. 10.65.

Tejnaksh Healthcare Ltd (539428) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Tejnaksh Healthcare Ltd (539428)
Brand: Tejnaksh Healthcare

Tejnaksh Healthcare Ltd (539428) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Tejnaksh Healthcare Ltd (539428)

BSE: 539428 NSE:

Key Metrics

Market Cap

₹31 Cr.

P/E Ratio

18.77

Price to Book (P/B)

1.16

Price to Sales (P/S)

3.92

EV/EBITDA

8.48

Return on Capital Employed (ROCE)

15.00%

Current Price

₹15.1

Return on Equity (ROE)

10.88%

Return on Assets (ROA)

8.87%

Operating Profit Margin

51%

Net Profit Margin

29.8%

Gross Profit Margin

50.6%

Book Value per Share

₹12.9

Sales Growth (YoY)

7.06%

Sales Growth (3 Years)

2.72%

Operating Profit Growth (1 Year)

23.01%

Operating Profit Growth (3 Years)

1.37%

Net Profit Growth (1 Year)

44.75%

52-Week Low / High

₹11 / 24

Net Profit Growth (3 Years)

1.34%

Dividend Yield

0.00%

Promoter Holding

73.83%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of Tejnaksh Healthcare Ltd?

Tejnaksh Healthcare Ltd revenue growth is 7.1% for FY-2025 , which is above its 5 year CAGR of -5.2% , indicating faster growth.

Q.1 Promoter shareholding and pledge status of Tejnaksh Healthcare Ltd?

Promoters hold 73.83% of the Tejnaksh Healthcare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Tejnaksh Healthcare Ltd vs industry peers?

Tejnaksh Healthcare Ltd revenue CAGR is -5.21% , compared to the industry median CAGR of 1.49% , indicating stable growth and maintaining its market share.

Q.1 Which industry/sub-sector does Tejnaksh Healthcare Ltd belong to?

Tejnaksh Healthcare Ltd belongs to the Healthcare sector, operating specifically within the Hospital & Healthcare Services segment.

Q.1 Stock return of Tejnaksh Healthcare Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 13.5% based on the current price.

DeciZen - make an informed investing decision on Tejnaksh Healthcare

Based on:

Data

M-Cap below 100cr DeciZen not available

Tejnaksh Healthcare stock performance

Key Ratios

Is Tejnaksh Healthcare Ltd an attractive stock to invest in?

1. Is Tejnaksh Healthcare Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Tejnaksh Healthcare Ltd is a good quality company.

2. Is Tejnaksh Healthcare Ltd undervalued or overvalued?

The key valuation ratios of Tejnaksh Healthcare Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Tejnaksh Healthcare Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Tejnaksh Healthcare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	46.3%	26.5%	26.3%	24.1%	16.6%	14.1%	15.9%	9.6%	11.4%	15%	-
Value Creation Index ⓘ	2.3	0.9	0.9	0.7	0.2	0.0	0.1	-0.3	-0.2	0.1	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	4.8	6.5	8.6	14	11.5	8.6	8.1	7.3	8.2	8.8	8
Sales YoY Gr.	-	37.5%	32%	62%	-17.6%	-25.6%	-5.1%	-9.6%	12%	7.1%	-
Adj EPS ⓘ	0.7	0.8	1.2	1.3	1	1	1.3	0.7	0.9	1.3	0.8
YoY Gr.	-	27.7%	44.6%	10.8%	-28.6%	4.2%	27.3%	-46%	30.9%	44.9%	-
BVPS (₹) ⓘ	3.1	3.9	5.1	6.4	7.4	8.4	9.6	10.3	11.2	12.5	12.9
Adj Net Profit ⓘ	1.3	1.7	2.4	2.7	1.9	2	2.6	1.4	1.8	2.6	2
Cash Flow from Ops. ⓘ	3.7	1.8	3.9	3.2	1	0.8	9.1	1.9	4.2	0.5	-
Debt/CF from Ops. ⓘ	0	3.6	2	2	7.2	5.9	0.8	3.4	1.2	2.2	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	7.1%	-5.2%	2.7%	7.1%
Adj EPS ⓘ	7.9%	6.3%	0.8%	44.9%
BVPSⓘ	16.9%	11.1%	9.1%	11.6%
Share Price	13.5%	-14.5%	-25.4%	-36.7%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	30.3	23.9	26.5	22.9	13.7	12.5	14	6.8	8.3	10.9	6.3
Op. Profit Mgn % ⓘ	48.3	43.8	49.3	25.9	31	42	53.7	42.8	44.5	51	41.2
Net Profit Mgn % ⓘ	27.8	26	28.2	19.3	16.7	23.5	31.4	18.8	22.1	29.8	20.8
Debt to Equity ⓘ	0	0.8	0.7	0.5	0.5	0.3	0.4	0.3	0.2	0	-
Working Cap Days ⓘ	33	33	62	65	123	258	199	113	105	140	100
Cash Conv. Cycle ⓘ	-39	-18	-22	-8	4	12	18	41	31	44	79

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 6.30%

Sales growth has been subdued in last 3 years 2.72%

Net Profit has been subdued in last 3 years 0.79%

Sales growth is not so good in last 4 quarters at -8.19%

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	0.8	0.7
TTM Sales (₹ Cr.)	7.8	11.5
BVPS (₹) ⓘ	12.9	13.2
Reserves (₹ Cr.) ⓘ	16	17
P/BV ⓘ	1.16	1.14
PE ⓘ	18.77	22.25

From the Market
52 Week Low / High (₹)	10.65 / 24.29
All Time Low / High (₹)	3.80 / 97.00
Market Cap (₹ Cr.)	30.6
Equity (₹ Cr.)	10.2
Face Value (₹)	5
Industry PE ⓘ	86.1

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Tejnaksh Healthcare - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	4.75	6.53	8.62	13.96	11.50	8.56	8.12	7.34	8.22	8.80
Operating Expenses ⓘ +	2.46	3.67	4.37	10.34	7.94	4.97	3.81	4.20	4.57	4.31
Manufacturing Costs	0.77	1.47	1.62	2.89	2.22	1.28	0.77	0.91	0.68	0.69
Material Costs	0.67	0.76	0.72	0.60	0.66	0.45	0.70	0.87	0.68	0.65
Employee Cost	0.20	0.55	0.96	2	1.64	0.92	0.69	0.78	0.79	0.77
Other Costs ⓘ	0.82	0.89	1.07	4.85	3.42	2.34	1.64	1.64	2.42	2.20
Operating Profit ⓘ	2.29	2.86	4.25	3.62	3.56	3.58	4.31	3.14	3.65	4.49
Operating Profit Margin (%)	48.3%	43.8%	49.3%	25.9%	30.9%	41.9%	53.1%	42.8%	44.4%	51.0%
Other Income ⓘ +	0.04	0.20	0.43	1.42	0.48	0.15	0.13	0.24	0.28	0.35
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0	0.19	0.96	0.77	0.80	0.54	0.48	0.62	0.70	0.39
Depreciation ⓘ	0.21	0.34	0.44	0.52	0.59	0.61	0.59	0.79	0.80	0.79
Profit Before Tax ⓘ	2.12	2.53	3.29	3.75	2.66	2.59	3.37	1.96	2.43	3.66
Tax ⓘ	0.80	0.84	0.86	1.06	0.74	0.59	0.85	0.58	0.62	1.04
Profit After Tax	1.32	1.69	2.43	2.69	1.92	2	2.52	1.38	1.81	2.62
PAT Margin (%)	27.8%	26.0%	28.2%	19.3%	16.7%	23.4%	31.0%	18.8%	22.1%	29.8%
Adjusted EPS (₹)	0.7	0.8	1.2	1.3	1.0	1.0	1.2	0.7	0.9	1.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	6.24	7.94	10.40	13.09	15.01	17.03	19.55	20.95	22.78	25.41
Share Capital ⓘ	1.10	2.21	2.21	10.16	10.16	10.16	10.16	10.16	10.16	10.16
Reserves ⓘ	5.14	5.73	8.19	2.93	4.85	6.87	9.40	10.79	12.62	15.25
Debt +	0	6.39	7.35	5.95	6.66	4.22	6.33	5.93	4.11	0.63
Long Term Debt	0	6.39	5.98	5.78	6.59	4.18	6.30	5.88	4.11	0.63
Short Term Debt	0	0	1.37	0.18	0.06	0.04	0.03	0.06	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0.21	0.28	0.35	0.32	0.26	0.16	0.15	0.28	0.14	0.15
Others Liabilities ⓘ	0.39	0.41	1.07	2.05	2.35	2.46	2.64	2.65	3.09	2.81
Total Liabilities ⓘ	6.84	15.02	19.16	21.41	24.28	23.87	28.68	29.80	30.11	29
Fixed Assets
Net Fixed Assets ⓘ +	3.34	13.43	14.54	16.19	16.59	14.34	14.55	22.51	22.14	20.14
Gross Block	4.10	14.53	14.98	17.15	18.14	16.31	16.88	25.59	26.01	24.80
Accumulated Depreciation	0.76	1.10	0.44	0.96	1.54	1.97	2.32	3.08	3.88	4.67
CWIP ⓘ	0	0	0	0.39	0.65	0.79	8.89	0.95	1.07	1.33
Investments ⓘ	2.59	0.07	1.06	1.06	1.06	1.06	1.06	1.06	1.06	1.06
Inventories	0.18	0.18	0.25	0.46	0.33	0.42	0.49	0.34	0.44	0.37
Trade Receivables	0	0	0	0.22	0.53	0.37	0.45	1.30	0.45	1.75
Cash Equivalents	0.49	0.75	1.39	0.97	1.03	0.56	2.44	2.47	3.94	1.64
Others Assets ⓘ	0.24	0.59	1.92	2.12	4.09	6.34	0.80	1.17	1.01	2.71
Total Assets ⓘ	6.84	15.02	19.16	21.41	24.28	23.87	28.68	29.80	30.11	29

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	3.67	1.78	3.88	3.15	1	0.84	9.13	1.90	4.15	0.48
PBT ⓘ	1.32	1.69	3.29	3.75	2.66	2.59	3.37	1.96	2.43	3.66
Adjustment ⓘ	2.33	0.34	1.40	1.28	1.39	1.16	1.07	1.30	1.67	1.06
Changes in Working Capital ⓘ	0.01	-0.26	0.02	-1.1	-2.75	-3.41	4.45	-1.74	0.38	-3.75
Tax Paid ⓘ	0	0	-0.82	-0.78	-0.30	0.49	0.24	0.39	-0.33	-0.50
Cash Flow From Investing Activity ⓘ +	-3.26	-7.91	-2.59	-1.49	-1.16	1.56	-10.40	-0.98	-1.08	3.58
Capex	-0.68	-10.43	-0.84	-1.11	-1.02	1.63	-8.83	-0.68	-0.42	1.21
Net Investments	-2.58	2.52	-1.75	0	0	0	0	0	0	0
Others ⓘ	0	0	0	-0.38	-0.14	-0.07	-1.56	-0.30	-0.65	2.37
Cash Flow From Financing Activity ⓘ +	-0.13	6.39	-0.64	-2.08	0.22	-2.86	1.61	-1.17	-2.31	-3.86
Net Proceeds from Shares ⓘ	0.30	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-0.43	6.39	-0.11	-0.08	1.03	-2.32	2.12	-0.60	-1.62	-3.48
Interest Paid ⓘ	0	0	-0.91	-0.81	-0.70	-0.52	-0.49	-0.59	-0.63	-0.38
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0.37	-1.19	-0.11	-0.02	-0.01	0.02	-0.07	-0.01
Net Cash Flow ⓘ	0.29	0.26	0.64	-0.42	0.06	-0.47	0.35	-0.25	0.75	0.20

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	30.28	23.91	26.52	22.93	13.69	12.51	13.77	6.81	8.29	10.88
ROCE (%)	46.34	26.48	26.25	24.12	16.58	14.14	15.87	9.57	11.39	15
Asset Turnover Ratio	0.92	0.6	0.5	0.69	0.5	0.36	0.31	0.25	0.27	0.3
PAT to CFO Conversion(x)	2.78	1.05	1.6	1.17	0.52	0.42	3.62	1.38	2.29	0.18
Working Capital Days
Receivable Days	0	0	0	6	12	19	18	44	39	46
Inventory Days	12	10	9	9	13	16	20	21	17	17
Payable Days	165	118	160	204	160	172	81	91	112	82

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Tejnaksh Healthcare Ltd FAQs

The current trading price of Tejnaksh Healthcare on 17-Apr-2026 16:59 is ₹15.06.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2026 the market cap of Tejnaksh Healthcare stood at ₹30.59 Cr

The latest P/E ratio of Tejnaksh Healthcare as of 16-Apr-2026 is 18.77.

The latest P/B ratio of Tejnaksh Healthcare as of 16-Apr-2026 is 1.16.

The 52-week high of Tejnaksh Healthcare is ₹24.29 and the 52-week low is ₹10.65.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Tejnaksh Healthcare is ₹7.81 ( Cr.) .

About Tejnaksh Healthcare Ltd

No data to display

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Tejnaksh Healthcare Ltd (539428) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Tejnaksh Healthcare Share Price